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Abstract
Background: Developing efficient methods to isolate and identify human adipose-derived mesenchymal stem cells
(hADSCs) remains to be one of the major challenges in tissue engineering.
Methods: We demonstrate here a method by isolating hADSCs from abdominal subcutaneous adipose tissue
harvested during caesarian section. The hADSCs were isolated from human adipose tissue by collagenase digestion
and adherence to flasks.
Results: The yield reached around 1 × 10
6 hADSCs per gram adipose tissue. The following comprehensive
identification and characterization illustrated pronounced features of mesenchymal stem cells (MSCs). The
fibroblast-like hADSCs exhibited typical ultrastructure details for vigorous cell activities. Karyotype mapping showed
normal human chromosome. With unique immunophenotypes they were positive for CD29, CD44, CD73, CD105
and CD166, but negative for CD31, CD34, CD45 and HLA-DR. The growth curve and cell cycle analysis revealed
high capability for self-renewal and proliferation. Moreover, these cells could be functionally induced into
adipocytes, osteoblasts, and endothelial cells in the presence of appropriate conditioned media.
Conclusion: The data presented here suggest that we have developed high efficient isolation and cultivation
methods with a systematic strategy for identification and characterization of hADSCs. These techniques will be able
to provide safe and stable seeding cells for research and clinical application.
Background
Mesenchymal stem cells have been widely used in
experimental and clinical research because of their
unique biological characteristics and advantages [1-4]. In
a previous study, we have developed standardized tech-
niques for the isolation, culture, and differentiation of
bone marrow-derived mesenchymal stem cells [5-7].
Recent reports have shown that the widely-spreaded
human adipose tissue provides abundant source of
mesenchymal stem cells, which can be easily and safely
harvested as compared with human bone marrow
[8-10]. The adipose tissue from abdominal surgery or
liposuction is usually rich in stem cells which can meet
the needs of cell transplantation and tissue engineering
[11]. Meanwhile, these stem cells have high ability for
proliferation and multilineage differentiation [12,13].
Therefore, human adipose-derived mesenchymal stem
cell (hADSC) is becoming a potential source for stem
cell bank and an ideal source of seeding cells for tissue
engineering. Although some labs have successfully iso-
lated hADSCs from adipose tissues, there is still no any
widely-accepted efficient method for isolating and cul-
turing highly homogenous and undifferentiated hADSCs.
The comprehensive methods for identification and char-
acterization of hADSCs have not been fully established
yet. The aim of current study was to develop high effi-
cient methods to isolate and identify hADSCs.
Methods
Subjects
Human adipose tissue was obtained at caesarian section
from the abdominal subcutaneous tissue of obese
women delivered, in the maternity department at Jilin
University (age range: 23-41 years; mean = 32 years
old). The subjects were healthy without any regular
medication. Informed consent was obtained from the
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any medium, provided the original work is properly cited.subjects before the surgical procedure. The study proto-
col was approved by the Ethic Committee of Jilin Uni-
versity. After being removed, ~5 g adipose tissue sample
is relocated in a sterilized bottle filled with 0.1 M phos-
phate-buffered saline (PBS) at 4°C within 24 h prior to
use.
Isolation of hADSCs and Cell Culture
The procedure followed the description by Zuk et al.
[14] with some modifications. The adipose tissue sample
was extensively washed with sterile PBS containing 1000
U/ml penicillin and 1000 μg/ml streptomycin to remove
contaminating blood cells. The specimen was then cut
carefully. Connective tissue and blood vessels were
removed and the tissue was cut into 1 mm
3 pieces. The
extracellular matrix was digested with 0.1% collagenase
Type I (Invitrogen, USA) at 37°C, and shaken vigorously
for 60 min to separate the stromal cells from primary
adipocytes. The collagenase Type I activity was then
neutralized by adding an equal volume of Low glucose-
Dulbecco’s modified Eagle’s medium (L-DMEM,
Hyclone, USA) containing 10% fetal bovine serum (FBS,
Invitrogen, USA). Dissociated tissue was filtered to
remove debris, and centrifuged at 1500 rpm for 10 min.
The suspending portion containing lipid droplets was
discarded and the cell pellet was resuspended and
washed twice. Contaminating erythrocytes were lysed
with an osmotic buffer, and the remaining cells were
plated onto 6-well plate at a density of 1 × 10
6/ml. Plat-
ing and expansion medium consisted of L-DMEM with
10% FBS, 100 U/ml penicillin, and 100 mg/L streptomy-
cin. Cultures were maintained at 37°C with 5% CO2.
The medium was replaced after 48 hours, and then
every 3 days. Once the adherent cells were more than
80% confluent, they were detached with 0.25% trypsin-
0.02% EDTA, and re-plated at a dilution of 1:3.
Transmission Electron Microscopy
1×1 0
7 hADSCs or endothelial differentiated hADSCs
were washed twice in 0.1 M PBS, and then were centri-
fuged at 1500 rpm for 10 min. The pellet was pre-fixed
in 4% glutaraldehyde at 4°C overnight, then post-fixed
in 1% osmium tetroxide at 4°C for 60 min and further
dehydrated in acetone and embedded in epoxy resin.
Conventional ultrathin sections were prepared in Uranyl
acetate. After double-stained in lead citrate, they were
observed and photographed under transmission electron
microscope (JEM-1200EX) (JEOL Ltd., USA).
G-banding karyotype analysis
To analyze the karyotype of hADSCs within 12 passages,
cell division was blocked in mitotic metaphase by 0.1
μg/ml colcemid for 2 h. Then the cells were trypsinized,
resuspended in 0.075 M KCl solution, and incubated for
30 min at 37°C. The cells were fixed with methanol and
acetic acid mixed by 3:1 ratio. G-band standard staining
was used to observe the chromosome. Karyotypes were
analyzed and reported according to the International
System for Human Cytogenetic Nomenclature.
Immunophenotypic Characterization
2×1 0
5 hADSCs were incubated with primary antibo-
dies against human CD29, CD45, CD73, CD105, CD166,
HLA-DR (Biolegend, USA) and CD31, CD34, CD44 (BD
Biosciences, USA). All antibodies were diluted 1:100 and
incubated with cells for 30 min at room temperature.
We used same-species, same-isotype irrelevant antibody
as negative control. The cells were then washed twice in
PBS and incubated with fluorescein isothiocyanate
(FITC)-conjugated secondary antibodies (1:50 dilution)
for 30 min at 4°C. After two washing steps, cells were
resuspended in 300 μl PBS for flow cytometric analysis
and analyzed by fluorescein-activated cell sorting
(FACS) Calibur (BD Biosciences, USA).
Indirect Immunofluorescence assay
All hADSCs were processed as described previously [5].
Monoclonal antibodies against specific CD markers and
lineage-specific proteins were used. The fluorescence
signals were detected by laser scanning confocal micro-
scope (Olympus FV500, Japan).
Analysis of growth kinetics and cell cycle
Using cell counting, we analyzed the proliferative capa-
city of hADSCs from different passages. The cells were
seeded onto 24-well culture plates with 5 × 10
3 cells per
well and counted daily by trypan blue exclusion for one
week and cell growth curves were recorded. The cell
population doubling time (DT) of hADSCs was calcu-
lated with the Patterson formula [11]. For cell cycle
anaysis, 1 × 10
7cells were collected, fixed for 20 min at
4°C in 70% ethanol, and stained with 50 μg/ml propi-
dium iodide (PI) at 4°C for 30 min. DNA content was
analyzed by FACS Calibur using Cell Quest software
(BD Biosciences, USA) in 24 h. Under these conditions,
quiescent cells (G0/G1) were characterized by the mini-
mal RNA content and uniform DNA content. The
results of the study were expressed as mean ± standard
error, and statistical comparisons were made using the
two-sided Student’s t-test.
Adipogenic differentiation
Once culture-expanded cells reached ~80% confluent,
they were cultured in adipogenic medium for 2 weeks.
The medium consisted of L-DMEM supplemented with
10% FBS, 1 μmol/L dexamethasone, 50 μmol/L indo-
methacin, 0.5 mM 3-isobutyl-1-methyl-xanthine and 10
μM insulin. At the end of the culture, the cells were
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with Oil red-O solution to show lipid droplets in
induced cells [5,13,15]. To quantify retention of Oil red
O, stained adipocytes were extracted with 4% Igepal
CA630 (Sigma-Aldrich, USA) in isopropanol for 15 min,
and absorbance was measured by spectrophotometry at
520 nm.
Osteogenic differentiation
T h eh A D S C sw e r ei n d u c e df o r4w e e k si no s t e o g e n i c
medium containing L-DMEM, 10% FBS, 0.1 μMd e x a -
methasone, 200 μM ascorbic acid, 10 mM b-glycerol
phosphate [5]. After induction, osteoblasts were con-
firmed by cytochemical staining with alkaline phospha-
tase (ALP) to detect the alkaline phosphatase activity,
and then were stained with 40 mM Alizarin Red S dye
(pH 4.2) to detect mineralized matrix according to the
protocol described previously [16,17]. Phosphatase Sub-
strate Kit (Pierce, IL, USA) containing PNPP (p-nitro-
phenyl phosphate disodium salt) was used to quantify
the ALP activity in cell cultures. PNPP solution was pre-
pared by dissolving two PNPP tablets in 8 ml of distilled
water and 2 ml of diethanolamine substrate buffer. Cells
were plated at 5000 per well in 96 well plates and cul-
tured in OBM for 2 weeks. After washing twice with
PBS, cells were incubated with 100 μl/well PNPP solu-
tion at room temperature for 30 min. 50 μlo f2N
NaOH was added to each well to stop the reaction.
Non-cell plated wells treated by the same procedure
were used as blank control. The absorbance was mea-
sured at 405 nm in a kinetics ELISA reader (Spectra
MAX 250, Molecular Devices, CA, USA).
Semi-quantitative RT-PCR
Osteogenic or adipogenic specific marker-osteopontin
(OPN) or PPARg-2 gene expression was detected by
semi-quantitative reverse transcriptase-polymerase chain
reaction (sqRT-PCR). Total RNA was extracted from
uninduced hADSCs and induced hADSCs with Trizol
reagent (Invitrogen, USA). Using total RNA as template,
reverse transcription reactions were carried out with
oligo dT-adaptor primer. Then semi-quantitative PCR
amplification was performed for human OPN and
PPARg-2. The primers used are listed below: OPN spe-
cific primers, 5’-CCAAGTAAGTCCAACGAAAG-3’ and
5’-GGTGATGTCCTCGTCTGTA-3’;P P A R g-2 specific
primers, 5’-CATTCTGGCCCACCAACTT-3’ and 5’-
CCTTGCATCCTTCACAAGCA-3’; b-actin specific pri-
mers, 5’-CATGTACGTTGCTATCCAGGC-3’ and 5’-
CTCCTTAATGTCACGCACGAT-3’. PCR cycles were
as follows: 94°C for 2 minutes, (94°C for 30 seconds, 55°
C for 30 seconds, 72°C for 1 minute) × 35 cycles, 72°C
for 5 minutes. The PCR products were analyzed by elec-
trophoresis on 1.5% agarose gel and image acquisition
and data analysis were accomplished with Digital Gel
Image System (Tanon, China).
Endothelial differentiation and immunocytochemical
analysis
Endothelial differentiation was induced as described pre-
viously with some modifications [18-20]. A 24-well cell
culture plate was coated with fibronectin (FN) (5 μg/
cm
2) (BD Bioscience, USA) in each well. 1 × 10
4
hADSCs were seeded in plates and incubated for up to
15 days in endothelial differentiation medium containing
endothelial growth medium( E G M 2 - M V )( L o n z a ,U S A )
supplemented with 50 ng/mL vascular endothelial
growth factor-165 (VEGF165) (PeproTech, USA), 100 U/
mL penicillin, and 100 μg/mL streptomycin. 15 days
after endothelial differentiation started, the cells were
fixed with 4% paraformaldehyde for 10 min at room
temperature, and rinsed with PBS. The fixed cells were
then incubated for 1 hour at 37°C with mouse antibo-
dies against human CD31 or CD34 (BD Bioscience,
USA), KDR (NeoMarker, USA) at 1:500 dilution. After
incubation in a blocking solution containing 1% normal
goat serum, they were incubated with secondary antibo-
dies. A streptavidin-biotin peroxidase detection system
was used to detect antibody binding.
Results
Isolation method gave high yield of hADSCs with normal
morphological characters
The hADSCs were isolated from human adipose tissue by
collagenase digestion. One gram of adipose tissue could
g i v ey i e l du pt o1×1 0
6 hADSCs. They were passaged
every 4-5 days for a maximum of 12 passages without
major morphological alteration. The primary and pas-
saged cells all displayed typical fibroblast-like morpholo-
gical features with fusiform shape (Figure 1A, B).
Under the transmission electron microscope, most of
the hADSCs showed irregular morphology of nuclear
located at one side of the cell, and the cytoplasm con-
tained numerous mitochondria and rough endoplasmic
reticulums (Figure 1C). Abundant microvilli extended
from cell surface into the cytoplasm and formed inclu-
sion body-like structures (Figure 1D).
Karyotypes of two hADSC cultures were analyzed and
reported according to the International System for
Human Cytogenetic Nomenclature. Both results showed
normal female chromosome type (46, XX) with no chro-
mosome abnormalities observed (Figure 1E).
The cells from different passages expressed same MSC-
specific markers
To characterize the hADSCs population, CD marker
profile was examined. About 95% cells expressed CD29,
CD44, CD73, CD105 and CD166, which are accepted as
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contrast, the hematopoietic lineage markers CD31,
CD34, and CD45 were not detected. Additionally, the
major histocompatibility complex (MHC) class II (HLA-
DR) antigen was also negative (Figure 2A). There was
no statistical difference in the expression of these mar-
kers among all 12 passages (Figure 2B).
After indirect immunofluorescent staining, hADSCs
were observed by laser confocal scanning microscope.
Cells that were assayed with monoclonal antibodies
against the 6 MSC-specific markers showed green fluor-
escence, which confirmed the results above (Figure 2C).
Growth kinetics indicated high capacity of proliferation
The growth kinetics of viable hADSCs was determined
by cell counting with trypan blue exclusion method.
All of the growth curves from different passages dis-
played an initial lag phase of 2 days, a log phase at
exponential rate from 3 to 5 days, and a plateau phase.
According to the Patterson formula, the doubling time
in the log phase of the 3rd passage was 24.8 hours.
There was no significant difference in the growth rate
among different passages (Figure 3A). The DNA
content was analyzed by FACS Calibur and the cell
cycle was analyzed with the Cell Quest software. The
result showed that 15.1 ± 2.9% of the cells was in S
+G2/M phase (active proliferative phase) with the
remaining cells in G0/G1 phase (quiescent phase,
84.9% ± 2.9%) (Figure 3B).
The hADSCs had good mutilineage differentiate potential
After adipogenic induction for 3 days, the cell morphol-
ogy changed from long spindle-shape into a round or
polygonal shape. One week later, small bubble-shaped
oil red O-staining lipid droplets appeared in part of the
cells (Figure 4A). The size of lipid droplets increased
after two weeks, and most of the differentiated cells
showed red lipid droplet throughout the cytoplasm (Fig-
ure 4B). After induction for 2 weeks, adipocyte number
increased in time-dependent manner, which is con-
firmed by Oil red O staining followed by retention
quantification (Figure 4C). hADSCs being induced for 2
weeks displayed higher expression of the PPAR-g
mRNA than cells that had been induced for 1 week,
which confirmed the oil red O staining results (Figure
4D).
Figure 1 The morphological features and karyotype of hADSCs. The hADSCs are typical fibroblast-like cells with fusiform shape from the 3rd
passage (P3) (A) to the 12th passage (P12) (B) (Bars = 100 μm). Under transmission electron microscope, hADSCs exhibited irregular nuclear
morphology and abundant organelles (C), abundant microvilli with some inclusion body-like structures (arrow) (Bars = 500 nm) (D). (E) One of
two reports from G-banding karyotype analysis at P12 showed normal female chromosome type: 46, XX.
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for 2 weeks, osteoblast-like cells could be clearly demon-
strated by alkaline phosphatase (ALP) staining (Figure
5A, B) and ALP activity was increased as shown by
PNPP quantification (Figure 5C). In vitro mineralization
could be shown at later stage (4 weeks) by Alizarin red
staining (Figure 5D, E). A time-dependent increase of
another osteoblastic marker, osteopontin, was shown
with semi-quantitative RT-PCR analysis (Figure 5F).
After hADSCs had been cultured in endothelial differ-
entiation medium for 15 days, these cells were evaluated
for markers of endothelial differentiation.
Figure 2 The hADSCs expressed a unique set of CD markers. (A) Flow cytometry analysis disclosed that the 3rd passage (P3) were positive
for CD29, CD44, CD73, CD105 and CD166 with expression rates all up to 95%, but negative for CD31, CD34, CD45 and HLA-DR. (B) This
immunophenotype was consistent among different passages. (C) Merged images from immunofluorescent staining of CD antigens (green) and
propidium iodide (PI) staining of nuclei (red) demonstrated the same phenotype (Bars = 10 μm).
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lial phenotype with expression of known endothelial cell
markers including CD31, CD34, and KDR. In contrast,
undifferentiated cells did not express any of them (Fig-
ure 6A). Additionally, Weibel-Palade body, the specific
endothelial granule, was also observed by transmission
electron microscopy (Figure 6B).
Discussion
Seeding cell is one of the key elements in tissue engi-
neering. Recent reports have shown that hADSCs can
be easily harvested from adipose tissue without ethical
concern or problems of transplant rejection, and these
cells have high proliferation rates for in vitro expansion
with multilineage differentiation capacity [8-13]. Because
of these favorable characteristics, there is considerable
interest in the applications of hADSCs. Since Rodbell
first isolated preadipocytes from adipose tissue [21] a
variety of methods have been developed, but the purity
of isolated hADSCs is not high and the methods for
identification have not been fully developed. Therefore,
developing high efficient methods to isolate and identify
hADSCs would be very valuable.
As demonstrated in the present manuscript we have
established a simple and effective way to obtain high-
purity hADSCs by using collagenase digestion and
adherence screening. Isolated hADSCs proliferated at a
high rate and maintained a multipotentdifferentiation
capacity in vitro for up to 12 passages.
Since no unique molecular marker for mesenchymal
stem cells has been established we used multiple surface
markers for hADSCs identification. Mesenchymal stem
cells bind to extracellular matrix through surface anti-
gens which involve in cell-cell and cell-matrix interac-
tions [22], we therefore selected adhesion molecules,
including CD44, CD166, CD29 (a member of the integ-
rin family), and mesenchymal markers (such as CD73
and CD105). The results showed that the positive stain-
ing rate was 95% or more, and the hematopoietic/leuko-
cytic/endothelial markers such as CD31, CD34, CD45
and the major histocompatibility complex (MHC) class
II (HLA-DR) were negative. These data not only
excluded endothelial cell contamination, but also sug-
gested that the clinical application of hADSCs can
bypass MHC restriction. Consequently they were suita-
ble for allograft procedures, consistent with the report
of Aust [23]. In addition, the phenotypes of hADSCs
showed no significant difference between different pas-
sages, indicating that the cells can be stably amplified in
vitro for several passages. Ultrastructural imaging sug-
gested that hADSCs were quite active with high capacity
of protein synthesis and nutrients uptake as reported
before [24]. Most cells were in resting period of cell
cycle agreeing with the characteristics of human bone
marrow-derived mesenchymal stem cells [5]. The
Figure 3 Growth kinetics and cell cycle analysis. (A) The growth
curves showed no significant difference in the growth rate among
different passages. (B) 15.1 ± 2.9% of the cells was in S+G2/M phase
(active proliferative phase) (pink area) with the remaining cells in
G0/G1 phase (quiescent phase, 84.9% ± 2.9%) (blue area).
Figure 4 Adipogenic differentiation of hADSCs. The lipid was
detected by Oil-red O staining after induced for 1 week (A) and 2
weeks (B) (Bars = 100 μm). (C) Quantification of the adipogenesis
was done by extraction of the Oil red O retention. *P < 0.01. (D)
The expression of adipogenic specific marker PPAR-g was detected
by sqRT-PCR, lane 1: non-induced hADSCs control; lane 2: hADSCs
induced for 1 week; lane 3: hADSCs induced for 2 weeks.
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being induced for 2 weeks (B) (Bars = 100 μm) and ALP activity was quantified by PNPP analysis (C). *P < 0.01. Calcium nodule formation was
demonstrated by Alizarin red staining (D: non-induced control; E: induced for 4 weeks) (Bars = 100 μm). (F) The expression of the osteogenic
specific marker osteopontin (OPN) was detected by sqRT-PCR, lane 1: non-induced hADSCs control; lane 2: hADSCs induced for 2 weeks; lane 3:
hADSCs induced for 4 weeks.
Figure 6 Immunocytochemical analysis and ultrastructure of hADSCs under endothelial differentiation. (A) The expression of endothelial-
specific protein vascular endothelial growth factor receptor-2 (KDR), CD34 and CD31 were detected by diaminobenzidine staining of the
secondary antibody (Bars = 50 μm). (B) Ultrastructural images showed clear specific endothelial granule, the Weibel-Palade body (arrow) (Bars =
200 nm).
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teristic, namely, a high degree of proliferation. No chro-
mosomal abnormalities were observed in hADSCs of
passage 12, providing an experimental basis for the
safely clinical application of these cells. Furthermore,
our studies showed that hADSCs could differentiate into
osteoblasts, adipocytes and endothelia, which are typical
mesenchymal stem cell characteristics.
Conclusions
Taken together, this study developed an efficient
method for isolation and cultivation of a large amount
of hADSCs. It also established a systemic and compre-
hensive strategy to identify and characterize these cells.
These data will significantlyc o n t r i b u t et ot i s s u ee n g i -
neering by providing abundant seeding cells with high
quality.
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